NFL’s ALEX SMITH JOINS OXEIA INVESTOR WEBINAR EXPLORING WHAT COULD BECOME THE FIRST FDA-APPROVED CONCUSSION THERAPY
Live June 18 Event Gives Investors Access to a Potential Breakthrough in Brain Injury Treatment BOSTON, MA, UNITED STATES, June 10, 2026 /EINPresswire.com/ -- Oxeia Biopharmaceuticals will host a live investor webinar on June 18, 2026, from 2:00 …